Neurological diseases in Peru: a systematic analysis of the global burden disease study

Detalhes bibliográficos
Autor(a) principal: ALVA-DÍAZ,Carlos
Data de Publicação: 2020
Outros Autores: HUERTA-ROSARIO,Andrely, PACHECO-BARRIOS,Kevin, MOLINA,Roberto A., NAVARRO-FLORES,Alba, AGUIRRE-QUISPE,Wilfor, CUSTODIO,Nilton, TORO-PEREZ,Juan, MORI,Nicanor, ROMERO-SANCHEZ,Roberto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000500282
Resumo: ABSTRACT Background: Disease burden indicators assess the impact of disease on a population. They integrate mortality and disability in a single indicator. This allows setting priorities for health services and focusing resources. Objective: To analyze the burden of neurological diseases in Peru from 1990-2015. Methods: A descriptive study that used the epidemiological data published by the Institute for Health Metrics and Evaluation of Global Burden of Diseases from 1990 to 2015. Disease burden was measured using disability-adjusted life years (DALY) and their corresponding 95% uncertainty intervals (UIs), which results from the addition of the years of life lost (YLL) and years lived with disability (YLD). Results: The burden of neurological diseases in Peru were 9.06 and 10.65%, in 1990 and 2015, respectively. In 2015, the main causes were migraine, cerebrovascular disease (CVD), neonatal encephalopathy (NE), and Alzheimer’s disease and other dementias (ADD). This last group and nervous system cancer (NSC) increased 157 and 183% of DALY compared to 1990, respectively. Young population (25 to 44 years old) and older (>85 years old) were the age groups with the highest DALY. The neurological diseases produced 11.06 and 10.02% of the national YLL (CVD as the leading cause) and YLD (migraine as the main cause), respectively. Conclusion: The burden of disease (BD) increased by 1.6% from 1990 to 2015. The main causes were migraine, CVD, and NE. ADD and NSC doubled the DALY in this period. These diseases represent a significant cause of disability attributable to the increase in the life expectancy of our population among other factors. Priority actions should be taken to prevent and treat these causes.
id ABNEURO-1_45ac575c89404db6bc93d7ce791b0c36
oai_identifier_str oai:scielo:S0004-282X2020000500282
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Neurological diseases in Peru: a systematic analysis of the global burden disease studyCost of IllnessNeurologyEpidemiologyABSTRACT Background: Disease burden indicators assess the impact of disease on a population. They integrate mortality and disability in a single indicator. This allows setting priorities for health services and focusing resources. Objective: To analyze the burden of neurological diseases in Peru from 1990-2015. Methods: A descriptive study that used the epidemiological data published by the Institute for Health Metrics and Evaluation of Global Burden of Diseases from 1990 to 2015. Disease burden was measured using disability-adjusted life years (DALY) and their corresponding 95% uncertainty intervals (UIs), which results from the addition of the years of life lost (YLL) and years lived with disability (YLD). Results: The burden of neurological diseases in Peru were 9.06 and 10.65%, in 1990 and 2015, respectively. In 2015, the main causes were migraine, cerebrovascular disease (CVD), neonatal encephalopathy (NE), and Alzheimer’s disease and other dementias (ADD). This last group and nervous system cancer (NSC) increased 157 and 183% of DALY compared to 1990, respectively. Young population (25 to 44 years old) and older (>85 years old) were the age groups with the highest DALY. The neurological diseases produced 11.06 and 10.02% of the national YLL (CVD as the leading cause) and YLD (migraine as the main cause), respectively. Conclusion: The burden of disease (BD) increased by 1.6% from 1990 to 2015. The main causes were migraine, CVD, and NE. ADD and NSC doubled the DALY in this period. These diseases represent a significant cause of disability attributable to the increase in the life expectancy of our population among other factors. Priority actions should be taken to prevent and treat these causes.Academia Brasileira de Neurologia - ABNEURO2020-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000500282Arquivos de Neuro-Psiquiatria v.78 n.5 2020reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282x20200018info:eu-repo/semantics/openAccessALVA-DÍAZ,CarlosHUERTA-ROSARIO,AndrelyPACHECO-BARRIOS,KevinMOLINA,Roberto A.NAVARRO-FLORES,AlbaAGUIRRE-QUISPE,WilforCUSTODIO,NiltonTORO-PEREZ,JuanMORI,NicanorROMERO-SANCHEZ,Robertoeng2020-05-27T00:00:00Zoai:scielo:S0004-282X2020000500282Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2020-05-27T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Neurological diseases in Peru: a systematic analysis of the global burden disease study
title Neurological diseases in Peru: a systematic analysis of the global burden disease study
spellingShingle Neurological diseases in Peru: a systematic analysis of the global burden disease study
ALVA-DÍAZ,Carlos
Cost of Illness
Neurology
Epidemiology
title_short Neurological diseases in Peru: a systematic analysis of the global burden disease study
title_full Neurological diseases in Peru: a systematic analysis of the global burden disease study
title_fullStr Neurological diseases in Peru: a systematic analysis of the global burden disease study
title_full_unstemmed Neurological diseases in Peru: a systematic analysis of the global burden disease study
title_sort Neurological diseases in Peru: a systematic analysis of the global burden disease study
author ALVA-DÍAZ,Carlos
author_facet ALVA-DÍAZ,Carlos
HUERTA-ROSARIO,Andrely
PACHECO-BARRIOS,Kevin
MOLINA,Roberto A.
NAVARRO-FLORES,Alba
AGUIRRE-QUISPE,Wilfor
CUSTODIO,Nilton
TORO-PEREZ,Juan
MORI,Nicanor
ROMERO-SANCHEZ,Roberto
author_role author
author2 HUERTA-ROSARIO,Andrely
PACHECO-BARRIOS,Kevin
MOLINA,Roberto A.
NAVARRO-FLORES,Alba
AGUIRRE-QUISPE,Wilfor
CUSTODIO,Nilton
TORO-PEREZ,Juan
MORI,Nicanor
ROMERO-SANCHEZ,Roberto
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv ALVA-DÍAZ,Carlos
HUERTA-ROSARIO,Andrely
PACHECO-BARRIOS,Kevin
MOLINA,Roberto A.
NAVARRO-FLORES,Alba
AGUIRRE-QUISPE,Wilfor
CUSTODIO,Nilton
TORO-PEREZ,Juan
MORI,Nicanor
ROMERO-SANCHEZ,Roberto
dc.subject.por.fl_str_mv Cost of Illness
Neurology
Epidemiology
topic Cost of Illness
Neurology
Epidemiology
description ABSTRACT Background: Disease burden indicators assess the impact of disease on a population. They integrate mortality and disability in a single indicator. This allows setting priorities for health services and focusing resources. Objective: To analyze the burden of neurological diseases in Peru from 1990-2015. Methods: A descriptive study that used the epidemiological data published by the Institute for Health Metrics and Evaluation of Global Burden of Diseases from 1990 to 2015. Disease burden was measured using disability-adjusted life years (DALY) and their corresponding 95% uncertainty intervals (UIs), which results from the addition of the years of life lost (YLL) and years lived with disability (YLD). Results: The burden of neurological diseases in Peru were 9.06 and 10.65%, in 1990 and 2015, respectively. In 2015, the main causes were migraine, cerebrovascular disease (CVD), neonatal encephalopathy (NE), and Alzheimer’s disease and other dementias (ADD). This last group and nervous system cancer (NSC) increased 157 and 183% of DALY compared to 1990, respectively. Young population (25 to 44 years old) and older (>85 years old) were the age groups with the highest DALY. The neurological diseases produced 11.06 and 10.02% of the national YLL (CVD as the leading cause) and YLD (migraine as the main cause), respectively. Conclusion: The burden of disease (BD) increased by 1.6% from 1990 to 2015. The main causes were migraine, CVD, and NE. ADD and NSC doubled the DALY in this period. These diseases represent a significant cause of disability attributable to the increase in the life expectancy of our population among other factors. Priority actions should be taken to prevent and treat these causes.
publishDate 2020
dc.date.none.fl_str_mv 2020-05-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000500282
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000500282
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0004-282x20200018
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.78 n.5 2020
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212786426085376